Scarica l'app Stockscreener
140.97
3.93%
-5.705
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ORCL Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$146.67
Aprire:
$145.6
Volume 24 ore:
18.88M
Relative Volume:
0.71
Capitalizzazione di mercato:
$404.96B
Reddito:
$61.02B
Utile/perdita netta:
$15.61B
Rapporto P/E:
26.49
EPS:
5.3211
Flusso di cassa netto:
$-13.18B
1 W Prestazione:
-16.63%
1M Prestazione:
-26.84%
6M Prestazione:
-44.89%
1 anno Prestazione:
-17.92%
Intervallo 1D:
$139.15
$146.55
Intervallo di 1 settimana:
$139.15
$171.20
Portata 52W:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Nome
Oracle Corp
Settore
Industria
Telefono
(737) 867-1000
Indirizzo
2300 ORACLE WAY, AUSTIN, CA
Confronta ORCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
140.90 | 421.54B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
405.77 | 3.08T | 305.45B | 119.26B | 77.41B | 15.98 |
|
PLTR
Palantir Technologies Inc
|
133.32 | 332.58B | 4.48B | 1.63B | 2.10B | 0.6363 |
|
CRWD
Crowdstrike Holdings Inc
|
413.00 | 104.71B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
413.45 | 80.16B | 7.05B | 1.34B | 1.35B | 8.0234 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Ripresa | Goldman | Buy |
| 2025-12-11 | Reiterato | BMO Capital Markets | Outperform |
| 2025-12-03 | Iniziato | Wells Fargo | Overweight |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-13 | Reiterato | BMO Capital Markets | Outperform |
| 2025-10-09 | Iniziato | Robert W. Baird | Outperform |
| 2025-09-25 | Iniziato | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Reiterato | BMO Capital Markets | Outperform |
| 2025-09-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-09-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-09-09 | Reiterato | BMO Capital Markets | Outperform |
| 2025-07-17 | Iniziato | Scotiabank | Sector Outperform |
| 2025-07-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Reiterato | BMO Capital Markets | Outperform |
| 2025-06-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-18 | Reiterato | Guggenheim | Buy |
| 2025-06-13 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-04-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Iniziato | Stephens | Equal-Weight |
| 2025-03-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-03-03 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Aggiornamento | Melius | Hold → Buy |
| 2024-09-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-09-10 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-04-18 | Iniziato | Oppenheimer | Perform |
| 2024-03-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Aggiornamento | Argus | Hold → Buy |
| 2024-03-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-03-12 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-11-13 | Aggiornamento | Edward Jones | Hold → Buy |
| 2023-10-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Iniziato | HSBC Securities | Buy |
| 2023-09-14 | Aggiornamento | DZ Bank | Hold → Buy |
| 2023-09-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Aggiornamento | UBS | Neutral → Buy |
| 2023-06-13 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Downgrade | Societe Generale | Buy → Hold |
| 2023-01-18 | Iniziato | DA Davidson | Neutral |
| 2023-01-11 | Iniziato | Mizuho | Buy |
| 2023-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-10-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Iniziato | Berenberg | Hold |
| 2022-08-12 | Iniziato | Guggenheim | Buy |
| 2022-06-29 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Ripresa | Goldman | Sell |
| 2022-06-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Iniziato | Daiwa Securities | Neutral |
| 2022-03-29 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-12-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Aggiornamento | DZ Bank | Sell → Hold |
| 2021-12-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-12-10 | Reiterato | Barclays | Equal Weight |
| 2021-12-10 | Reiterato | Citigroup | Neutral |
| 2021-12-10 | Reiterato | Cowen | Outperform |
| 2021-12-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Reiterato | Piper Sandler | Neutral |
| 2021-12-10 | Reiterato | Societe Generale | Hold |
| 2021-12-10 | Reiterato | Stifel | Hold |
| 2021-12-10 | Reiterato | UBS | Neutral |
| 2021-12-10 | Reiterato | Wolfe Research | Peer Perform |
| 2021-11-16 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Deutsche Bank | Hold |
| 2021-09-14 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-09-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Downgrade | DZ Bank | Hold → Sell |
| 2021-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Iniziato | Wolfe Research | Peer Perform |
| 2021-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2021-04-01 | Ripresa | Wedbush | Neutral |
| 2021-03-22 | Ripresa | Evercore ISI | In-line |
| 2021-03-16 | Ripresa | Credit Suisse | Outperform |
| 2021-03-11 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Downgrade | Societe Generale | Buy → Hold |
| 2021-03-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Ripresa | Citigroup | Neutral |
| 2021-01-22 | Iniziato | Goldman | Sell |
| 2020-12-18 | Aggiornamento | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Ripresa | BofA Securities | Neutral |
| 2020-12-08 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Ripresa | UBS | Neutral |
| 2020-09-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2020-09-11 | Reiterato | Barclays | Equal Weight |
| 2020-09-11 | Reiterato | Credit Suisse | Outperform |
| 2020-09-11 | Reiterato | Goldman | Buy |
| 2020-09-11 | Reiterato | Jefferies | Hold |
| 2020-09-11 | Reiterato | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-09-11 | Reiterato | Stifel | Hold |
| 2020-09-11 | Reiterato | Wells Fargo | Overweight |
| 2020-06-19 | Downgrade | Argus | Buy → Hold |
| 2020-06-01 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Reiterato | BMO Capital Markets | Market Perform |
Mostra tutto
Oracle Corp Borsa (ORCL) Ultime notizie
3 Reasons to Hold Oracle Stock Despite 43% Decline in 6 Months - Zacks Investment Research
Oracle Could Cut 30,000 Jobs, Sell Cerner Amid Financial Challenges - Samfiru Tumarkin LLP
Oracle Stock (ORCL) Opinions on $45-50 Billion AI Capital Raise - Quiver Quantitative
Oracle Database@AWS adds new regions in Canada and Australia - Data Center Dynamics
Oracle's Larry Ellison is down an unmatched $49 billion this year after the plunge in software stocks - Yahoo! Finance Canada
INVESTOR ALERT: Oracle Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - PR Newswire
INVESTIGATION NOTICE: Oracle Bondholders (ORCL) Who - GlobeNewswire
Oracle plans massive layoffs as AI expansion triggers financial strain - NewsFirst Prime
Ashton Thomas Private Wealth LLC Purchases 4,965 Shares of Oracle Corporation $ORCL - MarketBeat
Cullen Capital Management LLC Decreases Stock Position in Oracle Corporation $ORCL - MarketBeat
Oracle Corporation $ORCL Shares Purchased by SBI Securities Co. Ltd. - MarketBeat
Triglav Investments D.O.O. Reduces Stock Holdings in Oracle Corporation $ORCL - MarketBeat
First Fiduciary Investment Counsel Inc. Has $14.68 Million Stock Holdings in Oracle Corporation $ORCL - MarketBeat
Oracle Found Its Place In AI, Now Comes The Hard Part - Seeking Alpha
SouthState Bank Corp Has $49.56 Million Position in Oracle Corporation $ORCL - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Raises Position in Oracle Corporation $ORCL - MarketBeat
Driving innovation in AI transformation and multicloud - Oracle
Titleist Asset Management LLC Has $4.54 Million Stock Holdings in Oracle Corporation $ORCL - MarketBeat
Oracle makes a public clarification on the deal that analysts say will be behind company laying off up to - Times of India
Scotiabank Cuts Oracle (ORCL) Target to $220, Keeps Sector Outperform - Finviz
Scotiabank cuts Oracle (ORCL) target to $220, keeps sector outperform - MSN
Composable Applications Market to Hit USD 56.11 Billion by 2035, Fueled by Demand for Agile and Modular Digital Solutions | Research by SNS Insider - GlobeNewswire Inc.
Oracle Oversold AI Infrastructure Spending, Investor Says - Law360
Oracle to train 15,000 students and professionals in West Bengal - CRN Asia
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Oracle Corporation Securities Class Action Lawsuit - Business Wire
ORCL INVESTOR ALERT: Oracle Corporation Investors with - GlobeNewswire
Bank of Valletta taps Oracle for agentic AI solutions - FinAi News
Oracle Bolsters Financing with Major Senior Notes Issuance - TipRanks
Oracle (ORCL) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Oracle Signs At-The-Market Equity Distribution Agreement With Multiple Sales Agents - TradingView
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm - Business Wire
Oracle Investor Sues Over Mounting Spending on AI Data Centers - Bloomberg Law News
Why Oracle Stock Fell Hard To Start 2026 - The Globe and Mail
Oracle analyst warns of 30,000 layoffs, asset sale as the cloud firm moves to tackle debt – ORCL stock falls pre-market - MSN
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Lawsuit - PR Newswire
Palmetto Grain Brokerage - Palmetto Grain Brokerage
30,000 Layoffs Could Soon Hit at Oracle. What Does That Mean for ORCL Stock? - Barchart.com
ROSEN, A LEADING LAW FIRM, Encourages Oracle Corporation Investors to Secure Counsel in ... - Bluefield Daily Telegraph
Oracle In Transition: Investor Prize Or Awkward Proposition? (NYSE:ORCL) - Seeking Alpha
Oracle financing plan removes key overhang, BMO says - Yahoo Finance
Oracle Teams Up With Canadian Healthcare Organizations To Launch Clinical AI Pilot ProjectOracle (NYSE:ORCL) - Benzinga
Oracle’s Record AI Capital Raise Reshapes Cloud Focus And Portfolio - simplywall.st
Lumeo health system selects Oracle AI tool for clinical documentation - StreetInsider
Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care - Finviz
Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care – Company AnnouncementFT.com - Financial Times
UBS cuts Oracle (ORCL) target but sees funding clarity as a catalyst - MSN
How is Oracle’s AI Changing Financial Institutions? - FinTech Magazine
UBS Cuts Oracle (ORCL) Target but Sees Funding Clarity as a Catalyst - Yahoo Finance
What Oracle’s TikTok Dance Can Teach Everyone About Good Data Governance - corporatecomplianceinsights.com
Oracle targets financial services gains with new agentic AI suite - IT Pro
Investor Demand: Oracle balances debt issuance with equity reflecting investor caution - fi-desk.com
Oracle Corp Azioni (ORCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.30%
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):